Article citationsMore>>

Bulloch, M.N., Hanna, C. and Giovane, R. (2017) Lumacaftor/Ivacaftor, a Novel Agent for the Treatment of Cystic Fibrosis Patients Who Are Homozygous for the F508del-CFTR Mutation. Expert Review of Clinical Pharmacology, 10, 1055-1072.
https://doi.org/10.1080/17512433.2017.1378094

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top